UA57001U - Method for prediction of risk of thrombolitic complications in patients with anti-phospholipid syndrome - Google Patents
Method for prediction of risk of thrombolitic complications in patients with anti-phospholipid syndromeInfo
- Publication number
- UA57001U UA57001U UAU201006873U UAU201006873U UA57001U UA 57001 U UA57001 U UA 57001U UA U201006873 U UAU201006873 U UA U201006873U UA U201006873 U UAU201006873 U UA U201006873U UA 57001 U UA57001 U UA 57001U
- Authority
- UA
- Ukraine
- Prior art keywords
- risk
- prediction
- patients
- complications
- thrombolitic
- Prior art date
Links
Abstract
Method for prediction of risk of thrombotic complications in patients with anti-phospholipid syndrome includes determination of aggregation of thombocytes, thrombocytopenia, activation of PAI-1, protein C and S, activity of bera-2-glicoprotein 1, activity of pro-inflammation cytokines IL-1, IL-6, FNP-alpha. At increase of levels of the last ones one predicts risk of thrombosis.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
UAU201006873U UA57001U (en) | 2010-06-03 | 2010-06-03 | Method for prediction of risk of thrombolitic complications in patients with anti-phospholipid syndrome |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
UAU201006873U UA57001U (en) | 2010-06-03 | 2010-06-03 | Method for prediction of risk of thrombolitic complications in patients with anti-phospholipid syndrome |
Publications (1)
Publication Number | Publication Date |
---|---|
UA57001U true UA57001U (en) | 2011-02-10 |
Family
ID=50830439
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
UAU201006873U UA57001U (en) | 2010-06-03 | 2010-06-03 | Method for prediction of risk of thrombolitic complications in patients with anti-phospholipid syndrome |
Country Status (1)
Country | Link |
---|---|
UA (1) | UA57001U (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US11143659B2 (en) | 2015-01-27 | 2021-10-12 | Arterez, Inc. | Biomarkers of vascular disease |
-
2010
- 2010-06-03 UA UAU201006873U patent/UA57001U/en unknown
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US11143659B2 (en) | 2015-01-27 | 2021-10-12 | Arterez, Inc. | Biomarkers of vascular disease |
US11821905B2 (en) | 2015-01-27 | 2023-11-21 | Arterez, Inc. | Biomarkers of vascular disease |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PH12017501417A1 (en) | Anti-fap antibodies and methods of use | |
CY1124698T1 (en) | IL-18 BINDING PROTEIN (IL-18BP) IN INFLAMMATORY DISEASES | |
MX355256B (en) | Anti-il-17a/il-17f cross-reactive antibodies and methods of use thereof. | |
PH12015501656A1 (en) | Anti-il-33 antibodies and use thereof | |
PH12016500331A1 (en) | Survival benefit in patients with solid tumors with elevated c-reactive protein levels | |
WO2011154139A3 (en) | Gene expression markers for predicting response to interleukin-6 receptor-inhibiting monoclonal antibody drug treatment | |
MX348013B (en) | Anti-il-17f antibodies and methods of use thereof. | |
CR20120371A (en) | PCSK9 ANTAGONISTS | |
EP2542581A4 (en) | Antibody specific for apolipoprotein and methods of use thereof | |
EA201301180A1 (en) | BCMA-BASED STRATIFICATION AND THERAPY OF PATIENTS SUFFERING WITH MULTIPLE MYELOMA | |
MX355268B (en) | ANTI-N3pGlu AMYLOID BETA PEPTIDE ANTIBODIES AND USES THEREOF. | |
EA201491388A1 (en) | RECOMBINANT PROTEINS OF FACTOR VIII | |
PA8847001A1 (en) | HIGH AFFINITY HUMAN ANTIBODIES FOR THE IL-4-HUMAN RECEIVER | |
MX370348B (en) | Targeted modified il-1 family members. | |
UA114277C2 (en) | Anti-angiogenesis therfpy for the treatment of ovarian cancer | |
UA113609C2 (en) | ANTIGENCY BINDING PROTEIN Binding HUMAN IL-23 | |
GB2488091A (en) | Humanized anti-interleukin 3 receptor alpha chain antibodies | |
PH12015502102B1 (en) | Reducing proinflammatory response | |
WO2009135861A3 (en) | Humanized antibodies against human interferon-alpha | |
NZ629828A (en) | Methods for the treatment of b cell-mediated inflammatory diseases | |
UA109148C2 (en) | Compositions based on anti-vegfr-3 antibody | |
UA57001U (en) | Method for prediction of risk of thrombolitic complications in patients with anti-phospholipid syndrome | |
MX2015015232A (en) | Monoclonal antibody directed against cxcr5. | |
GB201103780D0 (en) | Treatment for ige-mediated disease | |
UA60581U (en) | method for predicting the risk of thrombotic complications in fracture |